Shane Olwill
20Patents
2h-index
31Co-inventors
53Inventor score
Filing activity: Apr 10, 2006 → Jan 19, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10526382B2 | Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins capable of binding angiopoietin-2 (Ang-2) and methods of use thereof | Chemistry; Metallurgy | 5 | Active |
| US10526384B2 | Interleukin-17A-specific and interleukin-23-specific binding polypeptides and uses thereof | Physics | 3 | Active |
| US10501510B2 | Muteins of human tear lipocalin capable of binding lymphocyte-activation gene 3 (LAG-3) and methods of use thereof | Physics | 2 | Active |
| US8475803B2 | Assays for diagnosis of tuberculosis and uses thereof | Human Necessities | 2 | Active |
| US10064963B2 | Methods and compositions for treating disorders | Chemistry; Metallurgy | 0 | Active |
| US11261221B2 | Proteins specific for CD137 | Chemistry; Metallurgy | 0 | Active |
| US9321838B2 | Therapy targeting cathepsin S | Chemistry; Metallurgy | 0 | Active |
| US10865250B2 | Anti-cancer fusion polypeptide | Chemistry; Metallurgy | 0 | Active |
| US11919931B2 | Anti-cancer fusion polypeptide capable of binding both CD137 and glypican-3 (GPC3) | Chemistry; Metallurgy | 0 | Active |
| US10703810B2 | Fusion polypeptides which bind vascular endothelial growth factor a (VEGF-A) and angiopoietin-2 (Ang-2) | Chemistry; Metallurgy | 0 | Active |
| US11034738B2 | Nucleic acid molecules encoding human neutrophil gelatinase-associated lipocalin (hNGAL) which bind angiopoietin-2 (Ang-2) | Chemistry; Metallurgy | 0 | Active |
| US11773147B2 | Lipocalin muteins with binding affinity for LAG-3 | Physics | 0 | Active |
| US10927156B2 | Human tear lipocalin muteins which specifically bind lymphocyte activation gene-3 (LAG3) and method of use thereof to stimulate an immune response | Physics | 0 | Active |
| US12195503B2 | Proteins specific for CD137 | Chemistry; Metallurgy | 0 | Active |
| US8747849B2 | Antibody and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US8846868B2 | Anti-AREG/HB-EGF antibodies and treatment | Chemistry; Metallurgy | 0 | Active |
| US11168119B2 | Lipocalin muteins with binding affinity for LAG-3 | Physics | 0 | Active |
| US10927154B2 | Multi-specific polypeptide useful for localized tumor immunomodulation | Chemistry; Metallurgy | 0 | Active |
| US7939642B2 | Antibody and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10913778B2 | Anti-cancer fusion polypeptides, encoding nucleic acids and methods of using polypeptides | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.